STELARA is not a steroid as it is used to target underlying causes of psoriatic arthritis and plaque psoriasis.
Stelara blocks the action of IL-12 and IL-23, two proteins that may play a role in plaque psoriasis and active psoriatic arthritis.
STELARA is a kind of drug called a biologic drug.
STELARA is also known as Ustekinumab which is a drug that is used to reduce signs and symptoms of of active psoriatic arthritis, such as psoriasis and joint swelling.
It is also approved for the treatment of plaque psoriasis and moderate to severe, active Crohn's disease.
Stelara is a prescription medicine which is prescribed to be used to treat the symptoms of Plaque Psoriasis, Psoriatic Arthritis, Ulcerative Colitis and Crohn Disease.
Stelara can also be used alone or with other medications.
Stelara belongs to a class of drugs called Antipsoriatics, Systemic; Monoclonal Antibodies; Interleukin Inhibitors.
STELARA is also an immunosuppressant and when taken can increase the risk of malignancy.
Malignancies were reported among patients who received STELARA in clinical studies.
The safety of STELARA has not been evaluated in patients who have a history of malignancy or who have a known malignancy.
Stelara and Humira are both monoclonal antibodies.
Monoclonal antibodies mimic the effects of proteins made by your immune system.
Stelara contains the monoclonal antibody ustekinumab.
Ustekinumab belongs to a drug class* called interleukin-12 and interleukin-23 blockers.
Stelara may cause mild neurological side effects such as headache and dizziness.
But Stelara can also cause a more serious brain condition called posterior reversible leukoencephalopathy syndrome (PRES).
Bruising, itching, pain, redness, swelling, or hardening of the skin at the stelara injection site may occur.
Injection site reactions from stelara usually go away after 1 or 2 days.
Headache, back pain, or sinus/throat pain may also occur.
If any of these effects last or get worse, tell your doctor or pharmacist promptly.